Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder

Urologia Internationalis

Volumn 87, Issue 2, 2011, Pages 143-150

  Kramer, Mario Wolfgang ^a   Waalkes, Sandra ^a   Serth, Jürgen ^a   Hennenlotter, Jörg ^b   Tezval, Hossein ^a   Stenzl, Arnulf ^b   Kuczyk, Markus Antonius ^a   Merseburger, Axel Stuart ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bladder cancer; Galectin 8; Molecular marker; Tissue microarrays; Transitional cell carcinoma

Indexed keywords

GALECTIN 8;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; UNIVARIATE ANALYSIS;

AGED; CARCINOMA; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GALECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 80052779696     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000328439     Document Type: Article

References (30)

1. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL: Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999; 162: 702-707. (Pubitemid 29436854)
2. Herr HW: Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000; 163: 60-61; discussion 61-62.
3. Chopin DK, Gattegno B: Superficial bladder tumors. Eur Urol 2002; 42: 533-541. (Pubitemid 35462330)
4. van den Brule F, Califice S, Castronovo V: Expression of galectins in cancer: A critical review. Glycoconj J 2004; 19: 537-542.
5. Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y: Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem 1995; 270: 3447-3453.
6. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y: Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 2000; 113: 2385-2397. (Pubitemid 30599342)
7. Tribulatti MV, Cattaneo V, Hellman U, Mucci J, Campetella O: Galectin-8 provides costimulatory and proliferative signals to T lymphocytes. J Leukoc Biol 2009; 86: 371-380.
8. Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector JC, Zick Y, Salmon I, Danguy A, Kiss R, Gabius HJ: Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 2002; 50: 392-401. (Pubitemid 34161058)
9. Danguy A, Rorive S, Decaestecker C, Bronckart Y, Kaltner H, Hadari YR, Goren R, Zich Y, Petein M, Salmon I, Gabius HJ, Kiss R: Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol 2001; 16: 861-868. (Pubitemid 32700398)
10. Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, Andre S, Brinck U, Alken P, Gabius HJ: Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007; 51: 681-690. (Pubitemid 47572877)
11. Kramer MW, Kuczyk MA, Hennenlotter J, Serth J, Schilling D, Stenzl A, Merseburger AS: Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer. Oncol Rep 2008; 20: 1403-1408.
12. Mostofi FK, Sorbin L, Torloni H: Histological Typing of Urinary Bladder Tumours. International Classification of Tumours, ed 19. Geneva, World Health Organisation, 1973.
13. Kramer MW, Merseburger AS, Hennenlotter J, Kuczyk M: Tissue microarrays in clinical urology -technical considerations. Scand J Urol Nephrol 2007; 41: 478-484. (Pubitemid 350207539)
14. Merseburger AS, Anastasiadis AG, Hennenlotter J, Schilling D, Simon P, Machtens SA, Serth J, Stenzl A, Kuczyk MA: Tissue microarrays: Applications in urological cancer research. World J Urol 2006; 24: 579-584. (Pubitemid 44782311)
15. Merseburger AS, Kramer MW, Hennenlotter J, Serth J, Kruck S, Gracia A, Stenzl A, Kuczyk MA: Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival. World J Urol 2008; 26: 637-642.
16. Oda Y, Herrmann J, Gitt MA, Turck CW, Burlingame AL, Barondes SH, Leffler H: Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J Biol Chem 1993; 268: 5929-5939. (Pubitemid 23090929)
17. Gitt MA, Colnot C, Poirier F, Nani KJ, Barondes SH, Leffler H: Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract. J Biol Chem 1998; 273: 2954-2960. (Pubitemid 28133947)
18. Wada J, Kanwar YS: Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 1997; 272: 6078-6086. (Pubitemid 27102450)
19. Yang RY, Hsu DK, Yu L, Ni J, Liu FT: Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 2001; 276: 20252-20260.
20. Dong GW, Kim J, Park JH, Choi JY, Cho SI, Lim SC: Galectin-8 expression in laryngeal squamous cell carcinoma. Clin Exp Otorhinolaryngol 2009; 2: 13-19.
21. Caulet-Maugendre S, Birolleau S, Corbineau H, Bassen R, Desrues B, Bidon N, Delaval P, Ramee MP, Brichory F, Dazord L: Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes. Pathol Res Pract 2001; 197: 797-801. (Pubitemid 34036974)
22. Henno S, Brichory F, Langanay T, Desrues B, Bidon N, Delaval P, Ramee MP, Dazord L, Caulet-Maugendre S: Expression of Po66-CBP, a galectin-8, in different types of primary and secondary broncho-pulmonary tumors. Oncol Rep 2002; 9: 177-180.
23. Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB: Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci USA 1996; 93: 7252-7257. (Pubitemid 26243535)
24. Gopalkrishnan RV, Roberts T, Tuli S, Kang D, Christiansen KA, Fisher PB: Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene. Oncogene 2000; 19: 4405-4416.
25. Nagy N, Legendre H, Engels O, Andre S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I, Kiss R: Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 2003; 97: 1849-1858. (Pubitemid 36397258)
26. Sheikholeslam-Zadeh R, Decaestecker C, Delbrouck C, Danguy A, Salmon I, Zick Y, Kaltner H, Hassid S, Gabius HJ, Kiss R, Choufani G: The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas. Laryngoscope 2001; 111: 1042-1047. (Pubitemid 32523714)
27. Cindolo L, Benvenuto G, Salvatore P, Pero R, Salvatore G, Mirone V, Prezioso D, Altieri V, Bruni CB, Chiariotti L: Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas. Int J Cancer 1999; 84: 39-43. (Pubitemid 29059106)
28. Bidon N, Brichory F, Bourguet P, Le Pennec JP, Dazord L: Galectin-8: A complex subfamily of galectins (review). Int J Mol Med 2001; 8: 245-250.
29. Bidon N, Brichory F, Hanash S, Bourguet P, Dazord L, Le Pennec JP: Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line. Gene 2001; 274: 253-262. (Pubitemid 32817143)
30. Kramer MW, Golshani R, Merseburger AS, Knapp J, Garcia A, Hennenlotter J, Duncan RC, Soloway MS, Jorda M, Kuczyk MA, Stenzl A, Lokeshwar VB: HYAL-1 hyaluronidase: A potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer. Eur Urol 2010; 57: 86-93.